Citi upgrades UPM Kymmene (0NV5) to a Buy
In a report released today, Ephrem Ravi from Citi upgraded UPM Kymmene (0NV5 – Research Report) to a Buy, with a price target of €36.00. The ...
Citi raises UPM-Kymmene stock rating, hikes target to €36
Citi analyst Ephrem Ravi adjusted the rating for UPM-Kymmene OYJ (UPM:FH) (OTC: UPMKY), elevating it from Neutral to Buy and increasing the price target significantly to €36.00, up from the previous ...
Cell Culture Hydrogel Market To Reach $2,136.7 Million, Globally, By 2035 At 15% CAGR: Allied Market Research
Request Sample of the Report on Global Cell Culture Hydrogel Market 2035 - The growth of the cell culture hydrogel market is driven by surge in prevalence of chronic diseases and aging population, ...